# Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-comparison-of-major-bleeding-risk-among-non-valvular-atrial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Allison Keshishian,Shital Kamble,Xianying Pan,Jack Mardekian,Ruslan Horblyuk,Melissa Hamilton,Gregory Y.H. Lip |
| Citations | 261 |
| DOI | 10.1160/th16-05-0403 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://vbn.aau.dk/da/publications/2a6491ff-5293-48a7-b4b9-7878de5b1904 |
| OpenAlex ID | https://openalex.org/W2520573665 |
| PMID | 27538358 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Jack Mardekian](https://scholariq.org/researchers/jack-mardekian/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.